Chestnut Hill, MA, United States of America

M Amin Arnaout

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 1.5

ph-index = 4

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 1992-2024

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: **M Amin Arnaout: A Pioneer in Integrin Antagonist Development**

Introduction

M Amin Arnaout, based in Chestnut Hill, MA, is an accomplished inventor renowned for his significant contributions to the field of integrin antagonists. With a remarkable portfolio that includes 17 patents, his innovations are paving the way for advanced treatments of critical health conditions.

Latest Patents

Among his latest patents are developments in integrin antagonists. These innovations provide methods for using compounds or polypeptides to treat serious medical disorders, including heart attacks, strokes, and cancer metastasis. Furthermore, he has created polypeptide integrin antagonists with methods for their preparation and applications in treating diseases associated with abnormal integrin levels or expression, demonstrating a clear commitment to addressing significant health challenges.

Career Highlights

M Amin Arnaout has garnered extensive experience working with notable institutions, including The General Hospital Corporation and Children's Medical Center Corporation. Through his tenure at these organizations, he has been able to explore and advance his research on integrin antagonists, contributing immensely to the scientific community and the field of medicine.

Collaborations

Throughout his career, Arnaout has collaborated with talented individuals, including coworkers Vineet Gupta and Rui Li. These collaborations have fostered a productive environment, leading to innovative solutions aimed at treating complex disorders.

Conclusion

M Amin Arnaout stands as a key figure in the advancement of integrin antagonists, with a strong focus on improving treatment options for serious health conditions. His extensive patent portfolio and collaborative efforts underscore his commitment to innovation and the betterment of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…